n-methyl-3,4-methylenedioxyamphetamine has been researched along with Myocardial Bridging in 2 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
Myocardial Bridging: A malformation that is characterized by a muscle bridge over a segment of the CORONARY ARTERIES. Systolic contractions of the muscle bridge can lead to narrowing of coronary artery; coronary compression; MYOCARDIAL ISCHEMIA; MYOCARDIAL INFARCTION; and SUDDEN CARDIAC DEATH.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zaami, S | 1 |
| De-Giorgio, F | 1 |
| Marinelli, E | 1 |
| Pellegrini, M | 1 |
| Pichini, S | 1 |
| Busardò, FP | 1 |
| Cerit, L | 1 |
| Duygu, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT04082546] | 10 participants (Actual) | Observational | 2016-11-26 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Myocardial Bridging
| Article | Year |
|---|---|
Myocardial bridging and ecstasy: A fatal combination involving a 22year-old male.
Topics: Fatal Outcome; Hallucinogens; Humans; Male; Myocardial Bridging; N-Methyl-3,4-methylenedioxyamphetam | 2016 |
Myocardial bridging and sudden death.
Topics: Death, Sudden, Cardiac; Hallucinogens; Humans; Myocardial Bridging; N-Methyl-3,4-methylenedioxyamphe | 2017 |